Onerous Concomitant Complications of Ulcerative Colitis: A Case Report

Zusammenfassung

Ulzerative Kolitis ist eine chronische Entzündung des Kolons, gekennzeichnet durch zeitweilige Exazerbation und Remission. Es kann durch Darmkrebs oder durch eine autoimmun bedingte, extraintestinale Manifestation erschwert werden. Wir stellen hier das Krankheitsbild einer Frau mit ulzerativer Kolitis dar, die die folgenden Krankheiten entwickelte: Sarkoidose, Darmkrebs, primär sklerosierende Cholangitis (PSC) und Gallengangskarzinom. Unserem Wissen nach wurden diese Symptome bisher noch nie bei einem Patienten in solch einer Kombination festgestellt.

Abstract

Ulcerative colitis is a chronic inflammatory disease of the colon characterized by intermittent exacerbations and remissions. It may be complicated with colon cancer or autoimmune-related extracolonic problems. Herein, we present a woman with ulcerative colitis who developed sarcoidosis, colon cancer, primary sclerosing cholangitis, and cholangiocarcinoma. To our knowledge, such associations in a patient have not been reported before.

ulzerative Kolitis - entzündliche Darmerkrankung - primär sklerosierende Cholangitis - Kolonkrebs - Gallengangkarzinom - malignes Cholangiom - Sarkoidose

autoimmune disease - ulcerative colitis - inflammatory bowel disease - primary sclerosing cholangitis - colon cancer - bile duct carcinoma - cholangiocarcinoma - sarcoidosis

References

• 1 Sartor R B. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn’s disease.  Gastroenterol Clin N Am. 1995;  24 475-507
• 2 Zeitz M. Pathogenesis of inflammatory bowel disease.  Digestion. 1997;  58 (Suppl 1) 59-61
• 3 Wee A, Ludwig J, Coffey R J. et al . Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis.  Hum Pathol. 1985;  16 719-726
• 4 Barr G D, Shale D J, Jewel D P. Ulcerative colitis and sarcoidosis.  Postgrad Med J. 1986;  62 341-345
• 5 Ilan Y, Rappaport I, Feigin R. et al . Primary sclerosing cholangitis in sarcoidosis.  J Clin Gastroenterol. 1993;  16 326-328
• 6 Alam I, Levenson S D, Ferrell L D. et al . Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis.  Dig Dis Sci. 1997;  42 1295-1301
• 7 Angulo P, Lındor K D. Primary sclerosing cholangitis.  Hepatology. 1999;  30 325-332
• 8 Eaden J, Abrams K, Ekbom A. et al . Colorectal cancer prevention in ulcerative colitis: a case-control study.  Aliment Pharmacol Ther. 2000;  14 145-153
• 9 Rabinowitz M, Gavaler J S, Schade R R. et al . Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occuring in the absence of inflammatory bowel disease? A study of sixty-six subjects.  Hepatology. 1990;  11 7-11
• 10 Nılubol N, Taub P J, Venturero M. et al . Ulcerative colitis and sarcoidosis.  Mountsinai J Med. 2001;  68 400-402
• 11 Herrlinger K R, Noftz M K, Dalhoff K. et al . Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.  Am J Gastroenterol. 2002;  97 377-381
• 12 Higenbottam T, Cochrane G M, Clarck T CH. et al . Bronchial disease in ulcerative colitis.  Thorax. 1980;  35 581-585
• 13 Storch I, Rosoff L, Katz S. Sarcoidosis and inflammatory bowel disease.  J Clin Gastroenterol. 2001;  33 345
• 14 Isenberg J I, Goldstein H, Korn A R. et al . Pulmonary vasculitis: an uncommon complication of ulcerative colitis.  N Engl J Med. 1968;  279 1376-1377
• 15 Delco F, Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis.  Gut. 2000;  46 500-506
• 16 Eaden J A, Abrams K R, Mayberry J F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis.  Gut. 2001;  48 526-535
• 17 Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patient with ulcerative colitis and concomitant primary sclerosing cholangitis? A populations based study.  Gut. 1997;  41 522-525
• 18 Loftus E V, Harewood G C, Loftus C G. et al . PSC-IBD: a unique form of inflammatory bowel diseaseassociated with primary sclerosing cholangitis.  Gut. 2005;  54 91-96
• 19 Bambha K, Kım W R, Talwalkar J. et al . Incidince, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States Community.  Gastroenterology. 2003;  125 1364-1369
• 20 Pungpapong S, Steers J L, Wallace M B. et al . Hepatobiliary sarcoidosis mimicking Klatskin’s cholangiocarcinoma.  Gastrointest Endosc. 2006;  64 124-125
• 21 Mir-Madjlessi S H, Sivak M V, Farmer R G. Hypereosinophilia, ulcerative colitis, sclerosing cholangitis, and bile duct carcinoma.  Am J Gastroenterol. 1986;  81 483-485
• 22 Suriawinata A A, Thung S N. Malignant liver tumors.  Clin Liver Dis. 2002;  6 527-554
• 23 Van Steenbergen W, Fevery J, Vandenbrande P. et al . Ulcerative colitis, primary sclerosing cholangitis, bile duct carcinom and generalized sarcoidosis.  J Clin Gastroenterol. 1987;  9 574-579
• 24 Spurkland A, Saarinen S, Boberg K M. et al . HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.  Tissue Antigens. 1999;  53 459-469
• 25 Saarinen S, Olerup O, Boome U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis.  Am J Gastroenterol. 2000;  95 3195-3199
• 26 Ueyama H, Kiyohara T, Sawada N. et al . High Fas ligand expression on lymhocytes in lesions of ulcerative colitis.  Gut. 1998;  43 48-55